Henri Brunengraber

8.8k total citations
185 papers, 6.0k citations indexed

About

Henri Brunengraber is a scholar working on Molecular Biology, Clinical Biochemistry and Physiology. According to data from OpenAlex, Henri Brunengraber has authored 185 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Molecular Biology, 85 papers in Clinical Biochemistry and 73 papers in Physiology. Recurrent topics in Henri Brunengraber's work include Metabolism and Genetic Disorders (85 papers), Diet and metabolism studies (68 papers) and Mitochondrial Function and Pathology (34 papers). Henri Brunengraber is often cited by papers focused on Metabolism and Genetic Disorders (85 papers), Diet and metabolism studies (68 papers) and Mitochondrial Function and Pathology (34 papers). Henri Brunengraber collaborates with scholars based in United States, Canada and France. Henri Brunengraber's co-authors include Charles R. Roe, John M. Lowenstein, France David, Christine Des Rosiers, Florian David, Mireille Boutry, Bernard R. Landau, Stephen F. Previs, M. Beylot and Takhar Kasumov and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Henri Brunengraber

182 papers receiving 5.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henri Brunengraber United States 44 3.2k 2.3k 1.8k 702 679 185 6.0k
Michael J. Bennett United States 44 4.1k 1.3× 1.8k 0.8× 2.4k 1.3× 748 1.1× 465 0.7× 185 7.5k
Peter J. Oates United States 31 2.2k 0.7× 1.8k 0.8× 2.0k 1.1× 689 1.0× 1.3k 1.9× 53 6.6k
C. Jakobs Netherlands 42 3.2k 1.0× 1.2k 0.5× 2.8k 1.5× 602 0.9× 695 1.0× 218 7.1k
Lodewijk IJlst Netherlands 46 4.8k 1.5× 1.6k 0.7× 3.5k 1.9× 262 0.4× 560 0.8× 154 7.2k
Yasuo Ido United States 47 4.3k 1.4× 3.7k 1.6× 907 0.5× 1.2k 1.7× 1.0k 1.5× 93 9.5k
Bernard R. Landau United States 42 2.7k 0.8× 2.3k 1.0× 895 0.5× 1.4k 2.0× 776 1.1× 161 6.0k
Christine Des Rosiers Canada 45 2.8k 0.9× 1.5k 0.7× 739 0.4× 479 0.7× 316 0.5× 139 5.3k
John M. Lowenstein United States 54 4.3k 1.4× 2.0k 0.9× 1.1k 0.6× 850 1.2× 1.5k 2.2× 131 8.1k
Z Drahota Czechia 38 3.1k 1.0× 1.7k 0.7× 689 0.4× 308 0.4× 448 0.7× 206 5.1k
Charles R. Roe United States 47 3.6k 1.1× 1.6k 0.7× 4.1k 2.3× 441 0.6× 466 0.7× 151 6.6k

Countries citing papers authored by Henri Brunengraber

Since Specialization
Citations

This map shows the geographic impact of Henri Brunengraber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henri Brunengraber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henri Brunengraber more than expected).

Fields of papers citing papers by Henri Brunengraber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henri Brunengraber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henri Brunengraber. The network helps show where Henri Brunengraber may publish in the future.

Co-authorship network of co-authors of Henri Brunengraber

This figure shows the co-authorship network connecting the top 25 collaborators of Henri Brunengraber. A scholar is included among the top collaborators of Henri Brunengraber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henri Brunengraber. Henri Brunengraber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Singh, Charandeep, Amit Sharma, George Hoppe, Henri Brunengraber, & Jonathan E. Sears. (2018). Serine metabolism is a key pathway involved in the prevention of oxygen-induced retinopathy by Roxadustat. Investigative Ophthalmology & Visual Science. 59(9). 5464–5464. 1 indexed citations
2.
Anand, Puneet, Alfred Hausladen, Yajuan Wang, et al.. (2014). Identification of S-nitroso-CoA reductases that regulate protein S-nitrosylation. Proceedings of the National Academy of Sciences. 111(52). 18572–18577. 71 indexed citations
3.
Zhang, Guofang, Sushabhan Sadhukhan, Gregory P. Tochtrop, & Henri Brunengraber. (2011). Metabolomics, Pathway Regulation, and Pathway Discovery. Journal of Biological Chemistry. 286(27). 23631–23635. 52 indexed citations
4.
Deng, Shuang, Guofang Zhang, Takhar Kasumov, Charles R. Roe, & Henri Brunengraber. (2009). Interrelations between C4 Ketogenesis, C5 Ketogenesis, and Anaplerosis in the Perfused Rat Liver. Journal of Biological Chemistry. 284(41). 27799–27807. 37 indexed citations
5.
Zhang, Guofang, Takhar Kasumov, Yong Hee Han, et al.. (2009). Catabolism of 4-Hydroxyacids and 4-Hydroxynonenal via 4-Hydroxy-4-phosphoacyl-CoAs. Journal of Biological Chemistry. 284(48). 33521–33534. 60 indexed citations
6.
Zhang, Guofang, John J. Mieyal, Vernon Anderson, et al.. (2009). Dynamics of glutathione and ophthalmate traced with2H-enriched body water in rats and humans. American Journal of Physiology-Endocrinology and Metabolism. 297(1). E260–E269. 28 indexed citations
7.
Kasumov, Takhar, et al.. (2007). Reassessment of the mechanisms by which aminooxyacetate (AOA) inhibits gluconeogenesis (GNG) from lactate. The FASEB Journal. 21(6). 4 indexed citations
8.
Kasumov, Takhar, et al.. (2006). Anaplerosis from propionate inhibits protein catabolism in the perfused rat heart.. The FASEB Journal. 20(4).
9.
Roe, Charles R., Lawrence Sweetman, Diane S. Roe, France David, & Henri Brunengraber. (2002). Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride. Journal of Clinical Investigation. 110(2). 259–269. 186 indexed citations
10.
Roe, Charles R., Lawrence Sweetman, Diane S. Roe, France David, & Henri Brunengraber. (2002). Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride. Journal of Clinical Investigation. 110(2). 259–269. 4 indexed citations
11.
Comte, Blandine, Takhar Kasumov, Michelle A. Puchowicz, et al.. (2002). Identification of phenylbutyrylglutamine, a new metabolite of phenylbutyrate metabolism in humans. Journal of Mass Spectrometry. 37(6). 581–590. 20 indexed citations
12.
Panchal, Ashish R., Blandine Comte, Hazel Huang, et al.. (2000). Partitioning of pyruvate between oxidation and anaplerosis in swine hearts. American Journal of Physiology-Heart and Circulatory Physiology. 279(5). H2390–H2398. 80 indexed citations
13.
Previs, Stephen F. & Henri Brunengraber. (1998). Methods for measuring gluconeogenesis in vivo. Current Opinion in Clinical Nutrition & Metabolic Care. 1(5). 461–465. 23 indexed citations
14.
Landau, Bernard R., John Wahren, Karin Ekberg, et al.. (1998). Limitations in estimating gluconeogenesis and Cori cycling from mass isotopomer distributions using [U-13C6]glucose. American Journal of Physiology-Endocrinology and Metabolism. 274(5). E954–E961. 29 indexed citations
15.
Previs, Stephen F., Christine Des Rosiers, M. Beylot, France David, & Henri Brunengraber. (1996). Assay of the13C and2H Mass Isotopomer Distribution of Phosphoenolpyruvate by Gas Chromatography/Mass Spectrometry. Journal of Mass Spectrometry. 31(6). 643–648. 7 indexed citations
16.
17.
Montgomery, Jane, Christine Des Rosiers, & Henri Brunengraber. (1992). Biosynthesis and characterization of 3-hydroxyalkan-2-ones and 2,3-alkanediols: Potential products of aldehyde metabolism. Journal of Mass Spectrometry. 21(5). 242–248. 6 indexed citations
18.
Fink, Gregor, Jane Montgomery, Florian David, et al.. (1990). Metabolism of beta-methyl-heptadecanoic acid in the perfused rat heart and liver.. PubMed. 31(11). 1823–30. 12 indexed citations
19.
Garneau, Michel, et al.. (1986). Ketogenesis in muscle: artifact or reality. Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States). 1 indexed citations
20.
Kopito, Ron R., et al.. (1984). The shunt pathway of mevalonate metabolism in the isolated perfused rat liver.. Journal of Biological Chemistry. 259(14). 8939–8944. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael J. Bennett Breakdown of academic impact, for papers by Peter J. Oates Breakdown of academic impact, for papers by C. Jakobs Breakdown of academic impact, for papers by Lodewijk IJlst Breakdown of academic impact, for papers by Yasuo Ido Breakdown of academic impact, for papers by Bernard R. Landau Breakdown of academic impact, for papers by Christine Des Rosiers Breakdown of academic impact, for papers by John M. Lowenstein Breakdown of academic impact, for papers by Z Drahota Breakdown of academic impact, for papers by Charles R. Roe
Rankless by CCL
2026